Why the study?
Secondary prevention medications are essential after cardiovascular events, but their use in older adults in community settings after discharge following PCI required evaluation.
Population
815 older adults discharged after PCI in a suburban city of Japan
Comparison
Pre-old group (63-72 years) vs old group (≥73 years) and sex
Design
Retrospective cohort study using claims data
Follow-up
3 months
Authors
Loading...
Low post-PCI statin and β-blocker rates in older adults signal gaps; leaves open whether interventions boost adherence or outcomes.
A substantial proportion of older adults in Japan do not receive all guideline-recommended secondary prevention medications after PCI, with notable underprescription of statins in those ≥73 years and β-blockers overall.
Shimada et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: